| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 10676647 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 609 journal articles in the PubMed database | Email to a friend | | |
| Foekens JA, Peters HA, Look MP, et al.
The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients. [Journal Article]
Cancer Res 2000 Feb 1; 60(3):636-43.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Look MP, van Putten WL, Duffy MJ, et al.
Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. [Journal Article, Meta-Analysis]
J Natl Cancer Inst 2002 Jan 16; 94(2):116-28.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Manders P, Tjan-Heijnen VC, Span PN, et al.
Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node-negative breast carcinoma. [Journal Article]
Cancer 2004 Aug 1; 101(3):486-94.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Grøndahl-Hansen J, Christensen IJ, Briand P, et al.
Plasminogen activator inhibitor type 1 in cytosolic tumor extracts predicts prognosis in low-risk breast cancer patients. [Journal Article]
Clin Cancer Res 1997 Feb; 3(2):233-9.
Abstract | Full Citation | Find Related Articles | | Foekens JA, Look MP, Peters HA, et al.
Urokinase-type plasminogen activator and its inhibitor PAI-1: predictors of poor response to tamoxifen therapy in recurrent breast cancer. [Journal Article]
J Natl Cancer Inst 1995 May 17; 87(10):751-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Jänicke F, Prechtl A, Thomssen C, et al.
Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Natl Cancer Inst 2001 Jun 20; 93(12):913-20.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Foekens JA, Schmitt M, van Putten WL, et al.
Plasminogen activator inhibitor-1 and prognosis in primary breast cancer. [Journal Article]
J Clin Oncol 1994 Aug; 12(8):1648-58.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Borstnar S, Vrhovec I, Svetic B, et al.
Prognostic value of the urokinase-type plasminogen activator, and its inhibitors and receptor in breast cancer patients. [Journal Article]
Clin Breast Cancer 2002 Jun; 3(2):138-46.
Abstract | Full Citation | Find Related Articles | | Heiss MM, Babic R, Allgayer H, et al.
Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system. [Journal Article]
J Clin Oncol 1995 Aug; 13(8):2084-93.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
